original ) (raw )Frequency of deaths in hepatitis C virus infected hepatocellular carcinoma patients and its relationship with raised serum alpha-fetoprotein levels
Dr. Fida H Shaikh
JPMA. The Journal of the Pakistan Medical Association, 2016
View PDFchevron_right
Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels
Samir afifi
Afro-Egyptian Journal of Infectious and Endemic Diseases, 2019
View PDFchevron_right
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma
Jessica Davila
Clinical Gastroenterology and Hepatology, 2011
View PDFchevron_right
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis
Giovanni Galati
Journal of Viral Hepatitis, 2018
View PDFchevron_right
Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma
Daniela Manuc
2020
View PDFchevron_right
Frequency of hepatocellular carcinoma in cirrhotic patients with hepatitis-C virus positive patients in Karachi-Pakistan
Muhammad Tariq
International Journal of Research in Medical Sciences, 2015
View PDFchevron_right
Evaluation of biomarkers for the detection of hepatocellular carcinoma in patients with hepatitis C virus
Nadia Y S Morcos
View PDFchevron_right
Diagnostic Accuracy of Alpha-fetoprotein for Hepatocellular Carcinoma in Hepatitis C Patients with Sustained Virological Response to Direct-acting Antivirals
Shimaa M Saied
View PDFchevron_right
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Myron Schwartz
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2017
View PDFchevron_right
Alpha Fetoprotein; Useful as Screening Test for Hepatocellular Carcinoma Due to Chronic Hepatitis C
Syed mir afzal Shah
THE PROFESSIONAL MEDICAL JOURNAL
View PDFchevron_right
Prevalence of Hepatocellular Carcinoma in Hepatitis C Patients
nida gulzar
2018
View PDFchevron_right
Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study
Dr hanan Soliman
Journal of the Egyptian National Cancer Institute, 2016
View PDFchevron_right
Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients
Aliyu Abdu , MATHIAS EMOKPAE
Nigerian Medical Journal, 2013
View PDFchevron_right
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies
M. Ananthavadivelu , R. Surendran , Jayanthi Venkataraman
International Journal of Infectious Diseases, 2008
View PDFchevron_right
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis
U. Visco-comandini
Digestive and Liver Disease, 2018
View PDFchevron_right
Evaluating the Serum Markers for Early Diagnosis of HCV Induced Hepatocellular Carcinoma
Navish Lodhi
2022
View PDFchevron_right
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
Mario Mondelli
2011
View PDFchevron_right
Predictive Markers for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis C Virus GENOTYPE4A
Ebtsam Zaher
Shiraz University of Medical Sciences, 2018
View PDFchevron_right
Association Between Alpha-Fetoprotein and Other Serological Markers in Patients with Hepatocellular Carcinoma: One Center's Experience
Damir Suljevic
Journal of IMAB - Annual Proceeding (Scientific Papers)
View PDFchevron_right
Frequency of elevated Hepatocellular Carcinoma (HCC) biomarkers in patients with advanced hepatitis C
Richard Sterling
2012
View PDFchevron_right
Correlation of Serum Alpha-Fetoprotein (AFP) Levels with the size of Hepatocellular carcinoma on Triphasic CT scan: A study in patients with the heterotrophic viral infection
Javeria Khan
Journal of Rawalpindi Medical College
View PDFchevron_right
Hepatitis C-related Hepatocellular Carcinoma: Prevalence Around the World, Factors Interacting, and Role of Genotypes
Robert Gish
Epidemiologic Reviews, 1999
View PDFchevron_right
The prevalence of anti-hepatitis C virus among chinese patients with hepatocellular carcinoma
Jaw-ching Wu
Cancer, 1992
View PDFchevron_right
Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas
Jee Kim
Annals of Hepatology, 2015
View PDFchevron_right
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection
Francesco Izzo
In Vivo
View PDFchevron_right
Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein
Brian Edlin
Liver international : official journal of the International Association for the Study of the Liver, 2004
View PDFchevron_right
Long-term Kinetics of Alpha-fetoprotein in Chronic Hepatitis C Patients Treated with Direct-acting Antivirals and Possible Predictive Role of AFP Response to Treatment on Development of Hepatocellular Carcinoma
Celal Ulasoglu
Viral Hepatitis Journal, 2021
View PDFchevron_right